Materias dentro de su búsqueda.
Mostrando 3,561 - 3,580 Resultados de 6,403 Para Buscar '"European Union"', tiempo de consulta: 0.20s Limitar resultados
  1. 3561
    “…To reduce this uncertainty, the European Union funded NANoREG and ProSafe projects (jointly referred to as N1P) have made a critical evaluation of methods to test and assess these risks in the context of the current registration, evaluation, authorisation and restriction of chemicals (REACH) regulation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Towards a more effective and efficient governance and regulation of nanomaterials
  2. 3562
    “…Based on a literature review and expert input, this study first identifies and assesses the major international, European Union, US and UK antibiotic R&D funding programmes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps
  3. 3563
    “…The PHARMINE (“Pharmacy Education in Europe”) project studied the organisation of pharmacy education, practice and legislation in the European Union (EU) with the objectives of evaluating to what degree harmonisation had taken place with the EU, and producing documents on each individual EU member state. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pharmacy Practice and Education in the Czech Republic †
  4. 3564
    “…Improving preparedness in the European region requires a clear understanding of what European Union (EU) member states should be able to do, whether acting internally or in cooperation with each other or the EU and other multilateral organizations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Public Health Preparedness Logic Model: Assessing Preparedness for Cross-border Threats in the European Region
  5. 3565
    “…Here, we assess the effectiveness of the Portuguese Natura 2000 (the European Union network of protected areas) in maintaining a species included in the Annex I of the Bird Directive, namely the population of a priority farmland bird, the little bustard Tetrax tetrax. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    EU protected area network did not prevent a country wide population decline in a threatened grassland bird
  6. 3566
    por Mesnage, Robin, Antoniou, Michael N.
    Publicado 2018
    “…Currently, the health risk assessment of pesticides in the European Union and in the United States focuses almost exclusively on the stated active principle. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ignoring Adjuvant Toxicity Falsifies the Safety Profile of Commercial Pesticides
  7. 3567
    “…We describe the seasonality and geographical spread of RSV infection in 15 countries of the European Union and European Economic Area. We performed a retrospective descriptive study of weekly laboratory-confirmed RSV detections between weeks 40/2010 and 20/2016, in patients investigated for influenza-like illness, acute respiratory infection or following the clinician’s judgment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016
  8. 3568
    “…Though imports of products of animal origin into the European Union (EU) have to comply with legal requirements and quality standards of the community, food consignment rejections at external EU borders have been increasing in recent years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The safety and quality of pork and poultry meat imports for the common European market received at border inspection post Hamburg Harbour between 2014 and 2015
  9. 3569
    “…Informed by the contribution of senior representatives of the European Union, the International Organization for Migration (IOM), Médecins Sans Frontières (MSF), and public health practitioners and investigators from over 30 countries, this editorial summarizes recommendations of the conference participants for improving migrant and minority health in Europe. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Migrant and minority health in Europe: the way forward: Report on the Salzburg Workshop on Migrant and Minority Health, 3–9 April 2016
  10. 3570
    “…PATIENTS AND METHODS: The study was conducted in community pharmacies within a European Union country that belongs to the professional research network. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The evaluation of pharmaceutical pictograms among elderly patients in community pharmacy settings – a multicenter pilot study
  11. 3571
    “…For certain zoonotic diseases such as cystic echinococcosis (average incidence of 3.99 per 100.000) and trichinellosis (average incidence of 0.8 per 100.000), the incidence exceeds several times the annual incidence recorded in the European Union. CONCLUSION: Parasitic diseases still pose a substantial problem with social and medical impacts on the residents of our country. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Human Parasitic Diseases in Bulgaria in Between 2013-2014
  12. 3572
    “…Since 2013, once a medicine receives marketing authorisation in the European Union, it is labelled with an inverted black triangle indicating all adverse reactions should be reported. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Awareness and compliance with pharmacovigilance requirements amongst UK oncology healthcare professionals
  13. 3573
    “…ECDC continues to act as a catalyst for sustaining continuous practice improvements and strengthening wider access to laboratory capacity across the European Union. Key priorities include optimization and broader use of rapid diagnostics, further integration of whole-genome sequencing in surveillance and electronic linkage of laboratory and public health systems. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Networking of Public Health Microbiology Laboratories Bolsters Europe’s Defenses against Infectious Diseases
  14. 3574
    “…Three anti-TNF biosimilar agents are approved for patients with rheumatic diseases in the European Union. The infliximab (Remicade®) biosimilars CT-P13 (Remsima® and Inflectra®) and SB2 (Flixabi®) and the etanercept (Enbrel®) biosimilar SB4 (Benepali®) have shown close comparability to their reference medicinal products, having undergone extensive evaluations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm
  15. 3575
    por Declerck, Paul, Farouk Rezk, Mourad
    Publicado 2017
    “…There are several biosimilars used in the field of rheumatology that are available in the European Union, or in development, that offer the potential to increase affordability/accessibility of biological treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The road from development to approval: evaluating the body of evidence to confirm biosimilarity
  16. 3576
    “…The objective of the study was to test the content validity of B3-MM as part of SCIROCCO (Scaling Integrated Care into Context), a European Union funded project. METHODS: A literature review was conducted to compare B3-MM’s 12 dimensions and their measurement scales with existing measures and instruments that focus on assessing the development of integrated care. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An Instrument to Measure Maturity of Integrated Care: A First Validation Study
  17. 3577
    “…Published in 2016, the Scottish Atlas of Palliative Care unlocks the possibility of benchmarking Scotland’s provision against other European Union (EU) countries. Our objectives were to describe the provision of SPC services in Scotland and compare this with other EU countries, assessing coverage against European norms. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The level of provision of specialist palliative care services in Scotland: an international benchmarking study
  18. 3578
    por Warheit, David B
    Publicado 2018
    “…Therefore, a variety of international planning activities or research efforts have been proposed or implemented, particularly in the European Union and United States, with the expectation that significant advances will be made in understanding potential hazards related to exposures in the occupational and/or consumer environments. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hazard and risk assessment strategies for nanoparticle exposures: how far have we come in the past 10 years?
  19. 3579
    “…Since incongruities exist between JECFA and the European Union standard, a novel regulatory review of the available data on this topic is desirable. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessment of Mycotoxin Exposure in Breastfeeding Mothers with Celiac Disease
  20. 3580
    “…METHODS: Data were drawn from the European Union Gene-Environment Interaction (EU-GEI) study. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    T132. ASSESSMENT OF CROSS-NATIONAL EQUIVALENCE OF THE COMMUNITY ASSESSMENT OF PSYCHIC EXPERIENCES (CAPE)
Herramientas de búsqueda: RSS